SBIR/STTR Research Award

Lowering the Cost of Imaging for Retinal Microvasculature in Diabetic Patients

Award identifier a7b24eb6504784487dca51c98da749cc4fadc55b9d9ccb69c5b8e4c99993a405Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$221,519

Program and phase

STTR · Phase I

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
AEON IMAGING LLC
Proposal award date
2015-09-01
Contract end date
2016-08-31
UEI
DLCKKJYC7NK3
Solicitation number
PA14-072
Topic code
W

Research abstract

DESCRIPTION provided by applicant Recently we found extensive remodeling of the microvasculature of the retina occurring in some diabetic patients much earlier than expected This provides the potential for novel biomarkers However the equipment is too expensive for most clinics and small practices These early retinal microvascular changes cannot be seen with routine clinical examination or traditional imaging devices We propose to reduce the cost and improve ease of use of this technology to allow widespread detection of retinal microvascular changes as biomarkers Part of the high cost of these devices is the adaptive optics AO subsystem which is deformable mirrors needed to provide compensation for the aberrations of the optics of the human eye By planning for high resolution but less than diffraction limited resolution a wider field of view and less extreme deformable mirror performance can be realized The important capillary changes will be nevertheless visualized in the retina We propose Aims In Aim we will optimize a lower cost retinal imager the Digital Light Ophthalmoscope DLO for high magnification and high contrast imaging that is sufficient to visualize retinal capillaries and cones outside the central fovea Aeon will build a DLO with a mid size for the field of view which provides an image sufficiently large to show capillary networks in a single image with the capillaries and cones being better visualized following image processing This also more readily allows the montaging of AO images taken sequentially for this Phase I proposal In Aim we will develop the AO subsystem for the AO DLO to correct aberrations of the human eye so that the high resolution images are high contrast We will use a commercially available visible wavelength deformable mirror and adapt the custom AO sensor and control techniques from existing custom software These Hartman Shack control algorithms and software are published and have been shared with other institutions One key feature is the ability to use a smaller region of the pupil in older subjects In Aim we wil develop an AO DLO by integrating AO with the DLO and map the microcirculation of the retina in normal subjects We will compare the capillary perfusion maps to corresponding maps from the AO Scanning Laser Ophthalmoscope AO SLO that was used discover the retinal microvascular changes For both AO DLO and AO SLO we will produce capillary maps by collecting a series of images from the AO DLO aligning them and plotting the variance of scaled images This is possible because the moving blood particles lead to differing amounts of reflectivity over time whereas the remaining retinal reflectivity is relatively unchanged in the wavelength range that we use Then we will compare the test retest of the capillary maps for each device vs the comparison of the two devices PUBLIC HEALTH RELEVANCE Recently we found extensive remodeling of the microvasculature of the retina occurring in some patients much earlier than expected These novel biomarkers are seen in diabetic retinas by using equipment that is too expensive for most clinics and small practices but these early retinal microvascular changes cannot be seen with routine clinical examination or traditional imaging devices We propose to reduce the cost and improve ease of use of this technology to allow widespread detection of microvascular changes as biomarkers

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

15 SBIR/STTR records share this UEI (2008–2022). Reported award amounts total $9,106,826. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.